nodes	percent_of_prediction	percent_of_DWPC	metapath
Buprenorphine—CYP2C18—Diphenhydramine—allergic rhinitis	0.0905	0.118	CbGbCtD
Buprenorphine—CYP2A6—Montelukast—allergic rhinitis	0.044	0.0573	CbGbCtD
Buprenorphine—CYP2C19—Desloratadine—allergic rhinitis	0.0317	0.0413	CbGbCtD
Buprenorphine—CYP1A2—Desloratadine—allergic rhinitis	0.0292	0.0381	CbGbCtD
Buprenorphine—CYP2C9—Desloratadine—allergic rhinitis	0.0263	0.0343	CbGbCtD
Buprenorphine—CYP2A6—Prednisolone—allergic rhinitis	0.0258	0.0336	CbGbCtD
Buprenorphine—ABCB1—Desloratadine—allergic rhinitis	0.0256	0.0333	CbGbCtD
Buprenorphine—CYP2D6—Desloratadine—allergic rhinitis	0.0241	0.0314	CbGbCtD
Buprenorphine—ABCG2—Hydrocortisone—allergic rhinitis	0.0226	0.0295	CbGbCtD
Buprenorphine—CYP2C8—Montelukast—allergic rhinitis	0.0217	0.0282	CbGbCtD
Buprenorphine—CYP2C8—Loratadine—allergic rhinitis	0.0217	0.0282	CbGbCtD
Buprenorphine—CYP2C19—Loratadine—allergic rhinitis	0.0182	0.0237	CbGbCtD
Buprenorphine—CYP2C19—Diphenhydramine—allergic rhinitis	0.0182	0.0237	CbGbCtD
Buprenorphine—CYP1A2—Diphenhydramine—allergic rhinitis	0.0168	0.0219	CbGbCtD
Buprenorphine—CYP3A7—Hydrocortisone—allergic rhinitis	0.0167	0.0218	CbGbCtD
Buprenorphine—CYP3A7-CYP3A51P—Hydrocortisone—allergic rhinitis	0.0167	0.0218	CbGbCtD
Buprenorphine—CYP3A4—Flunisolide—allergic rhinitis	0.0153	0.0199	CbGbCtD
Buprenorphine—CYP2A6—Dexamethasone—allergic rhinitis	0.0152	0.0198	CbGbCtD
Buprenorphine—CYP2C9—Montelukast—allergic rhinitis	0.0151	0.0197	CbGbCtD
Buprenorphine—CYP2C9—Loratadine—allergic rhinitis	0.0151	0.0197	CbGbCtD
Buprenorphine—CYP2C9—Diphenhydramine—allergic rhinitis	0.0151	0.0197	CbGbCtD
Buprenorphine—ABCB1—Loratadine—allergic rhinitis	0.0147	0.0191	CbGbCtD
Buprenorphine—CYP3A4—Olopatadine—allergic rhinitis	0.0144	0.0188	CbGbCtD
Buprenorphine—ABCG2—Dexamethasone—allergic rhinitis	0.0141	0.0183	CbGbCtD
Buprenorphine—CYP2D6—Loratadine—allergic rhinitis	0.0138	0.018	CbGbCtD
Buprenorphine—CYP2D6—Diphenhydramine—allergic rhinitis	0.0138	0.018	CbGbCtD
Buprenorphine—ABCB1—Methylprednisolone—allergic rhinitis	0.0134	0.0175	CbGbCtD
Buprenorphine—CYP3A5—Hydrocortisone—allergic rhinitis	0.0125	0.0163	CbGbCtD
Buprenorphine—CYP2C8—Hydrocortisone—allergic rhinitis	0.0121	0.0157	CbGbCtD
Buprenorphine—CYP3A7—Dexamethasone—allergic rhinitis	0.0104	0.0135	CbGbCtD
Buprenorphine—CYP3A7-CYP3A51P—Dexamethasone—allergic rhinitis	0.0104	0.0135	CbGbCtD
Buprenorphine—CYP3A4—Loratadine—allergic rhinitis	0.0088	0.0115	CbGbCtD
Buprenorphine—CYP3A4—Montelukast—allergic rhinitis	0.0088	0.0115	CbGbCtD
Buprenorphine—ABCB1—Betamethasone—allergic rhinitis	0.00873	0.0114	CbGbCtD
Buprenorphine—ABCB1—Prednisolone—allergic rhinitis	0.00861	0.0112	CbGbCtD
Buprenorphine—ABCB1—Hydrocortisone—allergic rhinitis	0.00817	0.0106	CbGbCtD
Buprenorphine—CYP3A4—Methylprednisolone—allergic rhinitis	0.00804	0.0105	CbGbCtD
Buprenorphine—CYP3A5—Dexamethasone—allergic rhinitis	0.0078	0.0102	CbGbCtD
Buprenorphine—CYP2C8—Dexamethasone—allergic rhinitis	0.0075	0.00977	CbGbCtD
Buprenorphine—CYP2C19—Dexamethasone—allergic rhinitis	0.00629	0.0082	CbGbCtD
Buprenorphine—CYP3A4—Triamcinolone—allergic rhinitis	0.0061	0.00794	CbGbCtD
Buprenorphine—CYP2C9—Dexamethasone—allergic rhinitis	0.00523	0.00681	CbGbCtD
Buprenorphine—CYP3A4—Betamethasone—allergic rhinitis	0.00523	0.00681	CbGbCtD
Buprenorphine—CYP3A4—Prednisolone—allergic rhinitis	0.00516	0.00672	CbGbCtD
Buprenorphine—ABCB1—Dexamethasone—allergic rhinitis	0.00508	0.00661	CbGbCtD
Buprenorphine—CYP3A4—Hydrocortisone—allergic rhinitis	0.00489	0.00637	CbGbCtD
Buprenorphine—CYP2D6—Dexamethasone—allergic rhinitis	0.00478	0.00623	CbGbCtD
Buprenorphine—CYP3A4—Dexamethasone—allergic rhinitis	0.00304	0.00396	CbGbCtD
Buprenorphine—Rash—Montelukast—allergic rhinitis	0.000117	0.000509	CcSEcCtD
Buprenorphine—Dermatitis—Montelukast—allergic rhinitis	0.000117	0.000508	CcSEcCtD
Buprenorphine—Ill-defined disorder—Prednisolone—allergic rhinitis	0.000116	0.000507	CcSEcCtD
Buprenorphine—Headache—Montelukast—allergic rhinitis	0.000116	0.000505	CcSEcCtD
Buprenorphine—Visual impairment—Dexamethasone—allergic rhinitis	0.000116	0.000505	CcSEcCtD
Buprenorphine—Visual impairment—Betamethasone—allergic rhinitis	0.000116	0.000505	CcSEcCtD
Buprenorphine—Mental disorder—Methylprednisolone—allergic rhinitis	0.000116	0.000505	CcSEcCtD
Buprenorphine—Erythema—Triamcinolone—allergic rhinitis	0.000115	0.000503	CcSEcCtD
Buprenorphine—Erythema—Methylprednisolone—allergic rhinitis	0.000115	0.000502	CcSEcCtD
Buprenorphine—Malnutrition—Methylprednisolone—allergic rhinitis	0.000115	0.000502	CcSEcCtD
Buprenorphine—Angioedema—Prednisolone—allergic rhinitis	0.000115	0.000499	CcSEcCtD
Buprenorphine—Ill-defined disorder—Hydrocortisone—allergic rhinitis	0.000114	0.000495	CcSEcCtD
Buprenorphine—Malaise—Prednisolone—allergic rhinitis	0.000113	0.000493	CcSEcCtD
Buprenorphine—Dysgeusia—Triamcinolone—allergic rhinitis	0.000113	0.000492	CcSEcCtD
Buprenorphine—Vertigo—Prednisolone—allergic rhinitis	0.000113	0.000491	CcSEcCtD
Buprenorphine—Syncope—Prednisolone—allergic rhinitis	0.000113	0.00049	CcSEcCtD
Buprenorphine—Eye disorder—Betamethasone—allergic rhinitis	0.000112	0.00049	CcSEcCtD
Buprenorphine—Eye disorder—Dexamethasone—allergic rhinitis	0.000112	0.00049	CcSEcCtD
Buprenorphine—Angioedema—Hydrocortisone—allergic rhinitis	0.000112	0.000488	CcSEcCtD
Buprenorphine—Back pain—Triamcinolone—allergic rhinitis	0.000112	0.000486	CcSEcCtD
Buprenorphine—Malaise—Hydrocortisone—allergic rhinitis	0.000111	0.000481	CcSEcCtD
Buprenorphine—Loss of consciousness—Prednisolone—allergic rhinitis	0.00011	0.00048	CcSEcCtD
Buprenorphine—Vertigo—Hydrocortisone—allergic rhinitis	0.00011	0.00048	CcSEcCtD
Buprenorphine—Nausea—Montelukast—allergic rhinitis	0.00011	0.000479	CcSEcCtD
Buprenorphine—Syncope—Hydrocortisone—allergic rhinitis	0.00011	0.000479	CcSEcCtD
Buprenorphine—Angiopathy—Betamethasone—allergic rhinitis	0.000109	0.000475	CcSEcCtD
Buprenorphine—Angiopathy—Dexamethasone—allergic rhinitis	0.000109	0.000475	CcSEcCtD
Buprenorphine—Convulsion—Prednisolone—allergic rhinitis	0.000109	0.000474	CcSEcCtD
Buprenorphine—Hypertension—Prednisolone—allergic rhinitis	0.000108	0.000472	CcSEcCtD
Buprenorphine—Loss of consciousness—Hydrocortisone—allergic rhinitis	0.000108	0.000469	CcSEcCtD
Buprenorphine—Ill-defined disorder—Triamcinolone—allergic rhinitis	0.000107	0.000466	CcSEcCtD
Buprenorphine—Ill-defined disorder—Methylprednisolone—allergic rhinitis	0.000107	0.000465	CcSEcCtD
Buprenorphine—Convulsion—Hydrocortisone—allergic rhinitis	0.000106	0.000463	CcSEcCtD
Buprenorphine—Hypertension—Hydrocortisone—allergic rhinitis	0.000106	0.000461	CcSEcCtD
Buprenorphine—Discomfort—Prednisolone—allergic rhinitis	0.000106	0.00046	CcSEcCtD
Buprenorphine—Angioedema—Triamcinolone—allergic rhinitis	0.000105	0.000459	CcSEcCtD
Buprenorphine—Angioedema—Methylprednisolone—allergic rhinitis	0.000105	0.000458	CcSEcCtD
Buprenorphine—Erythema—Dexamethasone—allergic rhinitis	0.000105	0.000456	CcSEcCtD
Buprenorphine—Erythema—Betamethasone—allergic rhinitis	0.000105	0.000456	CcSEcCtD
Buprenorphine—Myalgia—Hydrocortisone—allergic rhinitis	0.000104	0.000454	CcSEcCtD
Buprenorphine—Malaise—Triamcinolone—allergic rhinitis	0.000104	0.000453	CcSEcCtD
Buprenorphine—Anxiety—Hydrocortisone—allergic rhinitis	0.000104	0.000453	CcSEcCtD
Buprenorphine—Malaise—Methylprednisolone—allergic rhinitis	0.000104	0.000452	CcSEcCtD
Buprenorphine—Vertigo—Triamcinolone—allergic rhinitis	0.000104	0.000452	CcSEcCtD
Buprenorphine—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—allergic rhinitis	0.000104	0.000451	CcSEcCtD
Buprenorphine—Syncope—Triamcinolone—allergic rhinitis	0.000104	0.000451	CcSEcCtD
Buprenorphine—Vertigo—Methylprednisolone—allergic rhinitis	0.000103	0.000451	CcSEcCtD
Buprenorphine—Syncope—Methylprednisolone—allergic rhinitis	0.000103	0.00045	CcSEcCtD
Buprenorphine—Discomfort—Hydrocortisone—allergic rhinitis	0.000103	0.000449	CcSEcCtD
Buprenorphine—Oedema—Prednisolone—allergic rhinitis	0.000102	0.000446	CcSEcCtD
Buprenorphine—Anaphylactic shock—Prednisolone—allergic rhinitis	0.000102	0.000446	CcSEcCtD
Buprenorphine—Loss of consciousness—Triamcinolone—allergic rhinitis	0.000101	0.000442	CcSEcCtD
Buprenorphine—Loss of consciousness—Methylprednisolone—allergic rhinitis	0.000101	0.000441	CcSEcCtD
Buprenorphine—Shock—Prednisolone—allergic rhinitis	0.000101	0.000439	CcSEcCtD
Buprenorphine—Cough—Triamcinolone—allergic rhinitis	0.000101	0.000439	CcSEcCtD
Buprenorphine—Oedema—Hydrocortisone—allergic rhinitis	0.0001	0.000436	CcSEcCtD
Buprenorphine—Anaphylactic shock—Hydrocortisone—allergic rhinitis	0.0001	0.000436	CcSEcCtD
Buprenorphine—Convulsion—Triamcinolone—allergic rhinitis	0.0001	0.000436	CcSEcCtD
Buprenorphine—Tachycardia—Prednisolone—allergic rhinitis	0.0001	0.000435	CcSEcCtD
Buprenorphine—Convulsion—Methylprednisolone—allergic rhinitis	9.98e-05	0.000435	CcSEcCtD
Buprenorphine—Hypertension—Triamcinolone—allergic rhinitis	9.96e-05	0.000434	CcSEcCtD
Buprenorphine—Hypertension—Methylprednisolone—allergic rhinitis	9.94e-05	0.000433	CcSEcCtD
Buprenorphine—Infection—Hydrocortisone—allergic rhinitis	9.94e-05	0.000433	CcSEcCtD
Buprenorphine—Hyperhidrosis—Prednisolone—allergic rhinitis	9.9e-05	0.000431	CcSEcCtD
Buprenorphine—Shock—Hydrocortisone—allergic rhinitis	9.84e-05	0.000429	CcSEcCtD
Buprenorphine—Myalgia—Triamcinolone—allergic rhinitis	9.83e-05	0.000428	CcSEcCtD
Buprenorphine—Nervous system disorder—Hydrocortisone—allergic rhinitis	9.81e-05	0.000427	CcSEcCtD
Buprenorphine—Arthralgia—Methylprednisolone—allergic rhinitis	9.8e-05	0.000427	CcSEcCtD
Buprenorphine—Myalgia—Methylprednisolone—allergic rhinitis	9.8e-05	0.000427	CcSEcCtD
Buprenorphine—Anxiety—Methylprednisolone—allergic rhinitis	9.77e-05	0.000426	CcSEcCtD
Buprenorphine—Tachycardia—Hydrocortisone—allergic rhinitis	9.76e-05	0.000425	CcSEcCtD
Buprenorphine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—allergic rhinitis	9.74e-05	0.000424	CcSEcCtD
Buprenorphine—Skin disorder—Hydrocortisone—allergic rhinitis	9.72e-05	0.000423	CcSEcCtD
Buprenorphine—Ill-defined disorder—Dexamethasone—allergic rhinitis	9.72e-05	0.000423	CcSEcCtD
Buprenorphine—Ill-defined disorder—Betamethasone—allergic rhinitis	9.72e-05	0.000423	CcSEcCtD
Buprenorphine—Discomfort—Triamcinolone—allergic rhinitis	9.71e-05	0.000423	CcSEcCtD
Buprenorphine—Discomfort—Methylprednisolone—allergic rhinitis	9.69e-05	0.000422	CcSEcCtD
Buprenorphine—Hyperhidrosis—Hydrocortisone—allergic rhinitis	9.67e-05	0.000421	CcSEcCtD
Buprenorphine—Dry mouth—Triamcinolone—allergic rhinitis	9.61e-05	0.000419	CcSEcCtD
Buprenorphine—Angioedema—Dexamethasone—allergic rhinitis	9.57e-05	0.000417	CcSEcCtD
Buprenorphine—Angioedema—Betamethasone—allergic rhinitis	9.57e-05	0.000417	CcSEcCtD
Buprenorphine—Anorexia—Hydrocortisone—allergic rhinitis	9.54e-05	0.000415	CcSEcCtD
Buprenorphine—Confusional state—Methylprednisolone—allergic rhinitis	9.48e-05	0.000413	CcSEcCtD
Buprenorphine—Malaise—Dexamethasone—allergic rhinitis	9.44e-05	0.000411	CcSEcCtD
Buprenorphine—Malaise—Betamethasone—allergic rhinitis	9.44e-05	0.000411	CcSEcCtD
Buprenorphine—Anaphylactic shock—Triamcinolone—allergic rhinitis	9.42e-05	0.00041	CcSEcCtD
Buprenorphine—Oedema—Triamcinolone—allergic rhinitis	9.42e-05	0.00041	CcSEcCtD
Buprenorphine—Vertigo—Dexamethasone—allergic rhinitis	9.41e-05	0.00041	CcSEcCtD
Buprenorphine—Vertigo—Betamethasone—allergic rhinitis	9.41e-05	0.00041	CcSEcCtD
Buprenorphine—Anaphylactic shock—Methylprednisolone—allergic rhinitis	9.4e-05	0.000409	CcSEcCtD
Buprenorphine—Syncope—Dexamethasone—allergic rhinitis	9.39e-05	0.000409	CcSEcCtD
Buprenorphine—Syncope—Betamethasone—allergic rhinitis	9.39e-05	0.000409	CcSEcCtD
Buprenorphine—Infection—Triamcinolone—allergic rhinitis	9.36e-05	0.000408	CcSEcCtD
Buprenorphine—Hypotension—Hydrocortisone—allergic rhinitis	9.35e-05	0.000407	CcSEcCtD
Buprenorphine—Infection—Methylprednisolone—allergic rhinitis	9.34e-05	0.000407	CcSEcCtD
Buprenorphine—Shock—Triamcinolone—allergic rhinitis	9.27e-05	0.000404	CcSEcCtD
Buprenorphine—Insomnia—Prednisolone—allergic rhinitis	9.26e-05	0.000403	CcSEcCtD
Buprenorphine—Shock—Methylprednisolone—allergic rhinitis	9.25e-05	0.000403	CcSEcCtD
Buprenorphine—Nervous system disorder—Methylprednisolone—allergic rhinitis	9.22e-05	0.000401	CcSEcCtD
Buprenorphine—Loss of consciousness—Betamethasone—allergic rhinitis	9.2e-05	0.000401	CcSEcCtD
Buprenorphine—Loss of consciousness—Dexamethasone—allergic rhinitis	9.2e-05	0.000401	CcSEcCtD
Buprenorphine—Paraesthesia—Prednisolone—allergic rhinitis	9.2e-05	0.000401	CcSEcCtD
Buprenorphine—Tachycardia—Triamcinolone—allergic rhinitis	9.19e-05	0.0004	CcSEcCtD
Buprenorphine—Tachycardia—Methylprednisolone—allergic rhinitis	9.17e-05	0.000399	CcSEcCtD
Buprenorphine—Skin disorder—Methylprednisolone—allergic rhinitis	9.13e-05	0.000398	CcSEcCtD
Buprenorphine—Musculoskeletal discomfort—Hydrocortisone—allergic rhinitis	9.11e-05	0.000397	CcSEcCtD
Buprenorphine—Hyperhidrosis—Triamcinolone—allergic rhinitis	9.11e-05	0.000397	CcSEcCtD
Buprenorphine—Hyperhidrosis—Methylprednisolone—allergic rhinitis	9.09e-05	0.000396	CcSEcCtD
Buprenorphine—Convulsion—Dexamethasone—allergic rhinitis	9.07e-05	0.000395	CcSEcCtD
Buprenorphine—Convulsion—Betamethasone—allergic rhinitis	9.07e-05	0.000395	CcSEcCtD
Buprenorphine—Insomnia—Hydrocortisone—allergic rhinitis	9.05e-05	0.000394	CcSEcCtD
Buprenorphine—Hypertension—Betamethasone—allergic rhinitis	9.04e-05	0.000394	CcSEcCtD
Buprenorphine—Hypertension—Dexamethasone—allergic rhinitis	9.04e-05	0.000394	CcSEcCtD
Buprenorphine—Paraesthesia—Hydrocortisone—allergic rhinitis	8.98e-05	0.000391	CcSEcCtD
Buprenorphine—Myalgia—Betamethasone—allergic rhinitis	8.92e-05	0.000388	CcSEcCtD
Buprenorphine—Myalgia—Dexamethasone—allergic rhinitis	8.92e-05	0.000388	CcSEcCtD
Buprenorphine—Anxiety—Dexamethasone—allergic rhinitis	8.89e-05	0.000387	CcSEcCtD
Buprenorphine—Anxiety—Betamethasone—allergic rhinitis	8.89e-05	0.000387	CcSEcCtD
Buprenorphine—Discomfort—Dexamethasone—allergic rhinitis	8.81e-05	0.000384	CcSEcCtD
Buprenorphine—Discomfort—Betamethasone—allergic rhinitis	8.81e-05	0.000384	CcSEcCtD
Buprenorphine—Dyspepsia—Hydrocortisone—allergic rhinitis	8.81e-05	0.000384	CcSEcCtD
Buprenorphine—Hypotension—Methylprednisolone—allergic rhinitis	8.78e-05	0.000382	CcSEcCtD
Buprenorphine—Pain—Prednisolone—allergic rhinitis	8.76e-05	0.000381	CcSEcCtD
Buprenorphine—Decreased appetite—Hydrocortisone—allergic rhinitis	8.7e-05	0.000379	CcSEcCtD
Buprenorphine—Gastrointestinal disorder—Hydrocortisone—allergic rhinitis	8.64e-05	0.000376	CcSEcCtD
Buprenorphine—Fatigue—Hydrocortisone—allergic rhinitis	8.62e-05	0.000376	CcSEcCtD
Buprenorphine—Musculoskeletal discomfort—Triamcinolone—allergic rhinitis	8.58e-05	0.000374	CcSEcCtD
Buprenorphine—Musculoskeletal discomfort—Methylprednisolone—allergic rhinitis	8.56e-05	0.000373	CcSEcCtD
Buprenorphine—Pain—Hydrocortisone—allergic rhinitis	8.55e-05	0.000373	CcSEcCtD
Buprenorphine—Anaphylactic shock—Betamethasone—allergic rhinitis	8.55e-05	0.000372	CcSEcCtD
Buprenorphine—Anaphylactic shock—Dexamethasone—allergic rhinitis	8.55e-05	0.000372	CcSEcCtD
Buprenorphine—Oedema—Dexamethasone—allergic rhinitis	8.55e-05	0.000372	CcSEcCtD
Buprenorphine—Oedema—Betamethasone—allergic rhinitis	8.55e-05	0.000372	CcSEcCtD
Buprenorphine—Insomnia—Triamcinolone—allergic rhinitis	8.52e-05	0.000371	CcSEcCtD
Buprenorphine—Insomnia—Methylprednisolone—allergic rhinitis	8.5e-05	0.00037	CcSEcCtD
Buprenorphine—Infection—Betamethasone—allergic rhinitis	8.49e-05	0.00037	CcSEcCtD
Buprenorphine—Infection—Dexamethasone—allergic rhinitis	8.49e-05	0.00037	CcSEcCtD
Buprenorphine—Paraesthesia—Triamcinolone—allergic rhinitis	8.46e-05	0.000368	CcSEcCtD
Buprenorphine—Feeling abnormal—Prednisolone—allergic rhinitis	8.44e-05	0.000368	CcSEcCtD
Buprenorphine—Paraesthesia—Methylprednisolone—allergic rhinitis	8.44e-05	0.000368	CcSEcCtD
Buprenorphine—Shock—Betamethasone—allergic rhinitis	8.41e-05	0.000366	CcSEcCtD
Buprenorphine—Shock—Dexamethasone—allergic rhinitis	8.41e-05	0.000366	CcSEcCtD
Buprenorphine—Dyspnoea—Triamcinolone—allergic rhinitis	8.4e-05	0.000366	CcSEcCtD
Buprenorphine—OPRL1—G alpha (i) signalling events—PTGDR2—allergic rhinitis	8.39e-05	0.0327	CbGpPWpGaD
Buprenorphine—Nervous system disorder—Dexamethasone—allergic rhinitis	8.38e-05	0.000365	CcSEcCtD
Buprenorphine—Nervous system disorder—Betamethasone—allergic rhinitis	8.38e-05	0.000365	CcSEcCtD
Buprenorphine—Tachycardia—Dexamethasone—allergic rhinitis	8.34e-05	0.000363	CcSEcCtD
Buprenorphine—Tachycardia—Betamethasone—allergic rhinitis	8.34e-05	0.000363	CcSEcCtD
Buprenorphine—Dyspepsia—Triamcinolone—allergic rhinitis	8.29e-05	0.000361	CcSEcCtD
Buprenorphine—Dyspepsia—Methylprednisolone—allergic rhinitis	8.27e-05	0.00036	CcSEcCtD
Buprenorphine—Hyperhidrosis—Dexamethasone—allergic rhinitis	8.26e-05	0.00036	CcSEcCtD
Buprenorphine—Hyperhidrosis—Betamethasone—allergic rhinitis	8.26e-05	0.00036	CcSEcCtD
Buprenorphine—Feeling abnormal—Hydrocortisone—allergic rhinitis	8.24e-05	0.000359	CcSEcCtD
Buprenorphine—Gastrointestinal pain—Hydrocortisone—allergic rhinitis	8.18e-05	0.000356	CcSEcCtD
Buprenorphine—Anorexia—Dexamethasone—allergic rhinitis	8.15e-05	0.000355	CcSEcCtD
Buprenorphine—Anorexia—Betamethasone—allergic rhinitis	8.15e-05	0.000355	CcSEcCtD
Buprenorphine—Urticaria—Prednisolone—allergic rhinitis	8.14e-05	0.000354	CcSEcCtD
Buprenorphine—Fatigue—Triamcinolone—allergic rhinitis	8.12e-05	0.000354	CcSEcCtD
Buprenorphine—Fatigue—Methylprednisolone—allergic rhinitis	8.1e-05	0.000353	CcSEcCtD
Buprenorphine—Pain—Triamcinolone—allergic rhinitis	8.06e-05	0.000351	CcSEcCtD
Buprenorphine—Hypotension—Betamethasone—allergic rhinitis	7.99e-05	0.000348	CcSEcCtD
Buprenorphine—Hypotension—Dexamethasone—allergic rhinitis	7.99e-05	0.000348	CcSEcCtD
Buprenorphine—Urticaria—Hydrocortisone—allergic rhinitis	7.95e-05	0.000346	CcSEcCtD
Buprenorphine—Abdominal pain—Hydrocortisone—allergic rhinitis	7.91e-05	0.000344	CcSEcCtD
Buprenorphine—Body temperature increased—Hydrocortisone—allergic rhinitis	7.91e-05	0.000344	CcSEcCtD
Buprenorphine—Musculoskeletal discomfort—Betamethasone—allergic rhinitis	7.79e-05	0.000339	CcSEcCtD
Buprenorphine—Musculoskeletal discomfort—Dexamethasone—allergic rhinitis	7.79e-05	0.000339	CcSEcCtD
Buprenorphine—OPRL1—GPCRs, Class A Rhodopsin-like—PTGDR2—allergic rhinitis	7.78e-05	0.0303	CbGpPWpGaD
Buprenorphine—Feeling abnormal—Triamcinolone—allergic rhinitis	7.76e-05	0.000338	CcSEcCtD
Buprenorphine—Feeling abnormal—Methylprednisolone—allergic rhinitis	7.75e-05	0.000337	CcSEcCtD
Buprenorphine—Insomnia—Dexamethasone—allergic rhinitis	7.73e-05	0.000337	CcSEcCtD
Buprenorphine—Insomnia—Betamethasone—allergic rhinitis	7.73e-05	0.000337	CcSEcCtD
Buprenorphine—Gastrointestinal pain—Methylprednisolone—allergic rhinitis	7.69e-05	0.000335	CcSEcCtD
Buprenorphine—Paraesthesia—Betamethasone—allergic rhinitis	7.67e-05	0.000334	CcSEcCtD
Buprenorphine—Paraesthesia—Dexamethasone—allergic rhinitis	7.67e-05	0.000334	CcSEcCtD
Buprenorphine—Hypersensitivity—Prednisolone—allergic rhinitis	7.55e-05	0.000329	CcSEcCtD
Buprenorphine—OPRL1—Peptide ligand-binding receptors—CCL11—allergic rhinitis	7.54e-05	0.0294	CbGpPWpGaD
Buprenorphine—Dyspepsia—Dexamethasone—allergic rhinitis	7.52e-05	0.000328	CcSEcCtD
Buprenorphine—Dyspepsia—Betamethasone—allergic rhinitis	7.52e-05	0.000328	CcSEcCtD
Buprenorphine—Urticaria—Triamcinolone—allergic rhinitis	7.48e-05	0.000326	CcSEcCtD
Buprenorphine—Urticaria—Methylprednisolone—allergic rhinitis	7.47e-05	0.000325	CcSEcCtD
Buprenorphine—Body temperature increased—Triamcinolone—allergic rhinitis	7.45e-05	0.000324	CcSEcCtD
Buprenorphine—Abdominal pain—Methylprednisolone—allergic rhinitis	7.43e-05	0.000324	CcSEcCtD
Buprenorphine—Decreased appetite—Dexamethasone—allergic rhinitis	7.43e-05	0.000324	CcSEcCtD
Buprenorphine—Decreased appetite—Betamethasone—allergic rhinitis	7.43e-05	0.000324	CcSEcCtD
Buprenorphine—Gastrointestinal disorder—Betamethasone—allergic rhinitis	7.38e-05	0.000321	CcSEcCtD
Buprenorphine—Gastrointestinal disorder—Dexamethasone—allergic rhinitis	7.38e-05	0.000321	CcSEcCtD
Buprenorphine—Hypersensitivity—Hydrocortisone—allergic rhinitis	7.37e-05	0.000321	CcSEcCtD
Buprenorphine—Fatigue—Dexamethasone—allergic rhinitis	7.37e-05	0.000321	CcSEcCtD
Buprenorphine—Fatigue—Betamethasone—allergic rhinitis	7.37e-05	0.000321	CcSEcCtD
Buprenorphine—Pain—Betamethasone—allergic rhinitis	7.31e-05	0.000318	CcSEcCtD
Buprenorphine—Pain—Dexamethasone—allergic rhinitis	7.31e-05	0.000318	CcSEcCtD
Buprenorphine—Asthenia—Hydrocortisone—allergic rhinitis	7.18e-05	0.000313	CcSEcCtD
Buprenorphine—Pruritus—Hydrocortisone—allergic rhinitis	7.08e-05	0.000308	CcSEcCtD
Buprenorphine—Feeling abnormal—Dexamethasone—allergic rhinitis	7.04e-05	0.000307	CcSEcCtD
Buprenorphine—Feeling abnormal—Betamethasone—allergic rhinitis	7.04e-05	0.000307	CcSEcCtD
Buprenorphine—Gastrointestinal pain—Betamethasone—allergic rhinitis	6.99e-05	0.000304	CcSEcCtD
Buprenorphine—Gastrointestinal pain—Dexamethasone—allergic rhinitis	6.99e-05	0.000304	CcSEcCtD
Buprenorphine—Hypersensitivity—Triamcinolone—allergic rhinitis	6.94e-05	0.000302	CcSEcCtD
Buprenorphine—Hypersensitivity—Methylprednisolone—allergic rhinitis	6.92e-05	0.000302	CcSEcCtD
Buprenorphine—Diarrhoea—Hydrocortisone—allergic rhinitis	6.84e-05	0.000298	CcSEcCtD
Buprenorphine—Urticaria—Betamethasone—allergic rhinitis	6.79e-05	0.000296	CcSEcCtD
Buprenorphine—Urticaria—Dexamethasone—allergic rhinitis	6.79e-05	0.000296	CcSEcCtD
Buprenorphine—Dizziness—Prednisolone—allergic rhinitis	6.77e-05	0.000295	CcSEcCtD
Buprenorphine—Asthenia—Triamcinolone—allergic rhinitis	6.76e-05	0.000294	CcSEcCtD
Buprenorphine—Body temperature increased—Dexamethasone—allergic rhinitis	6.76e-05	0.000294	CcSEcCtD
Buprenorphine—Abdominal pain—Betamethasone—allergic rhinitis	6.76e-05	0.000294	CcSEcCtD
Buprenorphine—Abdominal pain—Dexamethasone—allergic rhinitis	6.76e-05	0.000294	CcSEcCtD
Buprenorphine—Body temperature increased—Betamethasone—allergic rhinitis	6.76e-05	0.000294	CcSEcCtD
Buprenorphine—Asthenia—Methylprednisolone—allergic rhinitis	6.74e-05	0.000294	CcSEcCtD
Buprenorphine—OPRL1—Class A/1 (Rhodopsin-like receptors)—PTGDR2—allergic rhinitis	6.67e-05	0.026	CbGpPWpGaD
Buprenorphine—Pruritus—Triamcinolone—allergic rhinitis	6.66e-05	0.00029	CcSEcCtD
Buprenorphine—Pruritus—Methylprednisolone—allergic rhinitis	6.65e-05	0.00029	CcSEcCtD
Buprenorphine—Dizziness—Hydrocortisone—allergic rhinitis	6.62e-05	0.000288	CcSEcCtD
Buprenorphine—Rash—Prednisolone—allergic rhinitis	6.46e-05	0.000281	CcSEcCtD
Buprenorphine—Dermatitis—Prednisolone—allergic rhinitis	6.45e-05	0.000281	CcSEcCtD
Buprenorphine—Diarrhoea—Methylprednisolone—allergic rhinitis	6.43e-05	0.00028	CcSEcCtD
Buprenorphine—Headache—Prednisolone—allergic rhinitis	6.42e-05	0.000279	CcSEcCtD
Buprenorphine—Vomiting—Hydrocortisone—allergic rhinitis	6.36e-05	0.000277	CcSEcCtD
Buprenorphine—Rash—Hydrocortisone—allergic rhinitis	6.31e-05	0.000275	CcSEcCtD
Buprenorphine—Dermatitis—Hydrocortisone—allergic rhinitis	6.3e-05	0.000274	CcSEcCtD
Buprenorphine—Headache—Hydrocortisone—allergic rhinitis	6.27e-05	0.000273	CcSEcCtD
Buprenorphine—Dizziness—Triamcinolone—allergic rhinitis	6.23e-05	0.000271	CcSEcCtD
Buprenorphine—Dizziness—Methylprednisolone—allergic rhinitis	6.22e-05	0.000271	CcSEcCtD
Buprenorphine—Asthenia—Betamethasone—allergic rhinitis	6.13e-05	0.000267	CcSEcCtD
Buprenorphine—Asthenia—Dexamethasone—allergic rhinitis	6.13e-05	0.000267	CcSEcCtD
Buprenorphine—OPRL1—GPCRs, Class A Rhodopsin-like—CYSLTR1—allergic rhinitis	6.11e-05	0.0238	CbGpPWpGaD
Buprenorphine—Nausea—Prednisolone—allergic rhinitis	6.08e-05	0.000265	CcSEcCtD
Buprenorphine—Pruritus—Betamethasone—allergic rhinitis	6.05e-05	0.000263	CcSEcCtD
Buprenorphine—Pruritus—Dexamethasone—allergic rhinitis	6.05e-05	0.000263	CcSEcCtD
Buprenorphine—Vomiting—Triamcinolone—allergic rhinitis	5.99e-05	0.000261	CcSEcCtD
Buprenorphine—Vomiting—Methylprednisolone—allergic rhinitis	5.98e-05	0.00026	CcSEcCtD
Buprenorphine—Nausea—Hydrocortisone—allergic rhinitis	5.94e-05	0.000259	CcSEcCtD
Buprenorphine—Rash—Triamcinolone—allergic rhinitis	5.94e-05	0.000259	CcSEcCtD
Buprenorphine—Dermatitis—Triamcinolone—allergic rhinitis	5.93e-05	0.000258	CcSEcCtD
Buprenorphine—Rash—Methylprednisolone—allergic rhinitis	5.93e-05	0.000258	CcSEcCtD
Buprenorphine—Dermatitis—Methylprednisolone—allergic rhinitis	5.92e-05	0.000258	CcSEcCtD
Buprenorphine—Headache—Triamcinolone—allergic rhinitis	5.9e-05	0.000257	CcSEcCtD
Buprenorphine—Headache—Methylprednisolone—allergic rhinitis	5.89e-05	0.000256	CcSEcCtD
Buprenorphine—Diarrhoea—Dexamethasone—allergic rhinitis	5.85e-05	0.000255	CcSEcCtD
Buprenorphine—Diarrhoea—Betamethasone—allergic rhinitis	5.85e-05	0.000255	CcSEcCtD
Buprenorphine—OPRM1—IL4-mediated signaling events—CCL11—allergic rhinitis	5.84e-05	0.0228	CbGpPWpGaD
Buprenorphine—Dizziness—Dexamethasone—allergic rhinitis	5.65e-05	0.000246	CcSEcCtD
Buprenorphine—Dizziness—Betamethasone—allergic rhinitis	5.65e-05	0.000246	CcSEcCtD
Buprenorphine—Nausea—Triamcinolone—allergic rhinitis	5.6e-05	0.000244	CcSEcCtD
Buprenorphine—Nausea—Methylprednisolone—allergic rhinitis	5.58e-05	0.000243	CcSEcCtD
Buprenorphine—OPRL1—Peptide ligand-binding receptors—TAC1—allergic rhinitis	5.48e-05	0.0213	CbGpPWpGaD
Buprenorphine—Vomiting—Betamethasone—allergic rhinitis	5.43e-05	0.000237	CcSEcCtD
Buprenorphine—Vomiting—Dexamethasone—allergic rhinitis	5.43e-05	0.000237	CcSEcCtD
Buprenorphine—Rash—Dexamethasone—allergic rhinitis	5.39e-05	0.000235	CcSEcCtD
Buprenorphine—Rash—Betamethasone—allergic rhinitis	5.39e-05	0.000235	CcSEcCtD
Buprenorphine—Dermatitis—Dexamethasone—allergic rhinitis	5.38e-05	0.000234	CcSEcCtD
Buprenorphine—Dermatitis—Betamethasone—allergic rhinitis	5.38e-05	0.000234	CcSEcCtD
Buprenorphine—Headache—Dexamethasone—allergic rhinitis	5.35e-05	0.000233	CcSEcCtD
Buprenorphine—Headache—Betamethasone—allergic rhinitis	5.35e-05	0.000233	CcSEcCtD
Buprenorphine—OPRL1—Class A/1 (Rhodopsin-like receptors)—CYSLTR1—allergic rhinitis	5.23e-05	0.0204	CbGpPWpGaD
Buprenorphine—OPRL1—GPCR ligand binding—PTGDR2—allergic rhinitis	5.08e-05	0.0198	CbGpPWpGaD
Buprenorphine—Nausea—Dexamethasone—allergic rhinitis	5.08e-05	0.000221	CcSEcCtD
Buprenorphine—Nausea—Betamethasone—allergic rhinitis	5.08e-05	0.000221	CcSEcCtD
Buprenorphine—OPRL1—Class A/1 (Rhodopsin-like receptors)—CCL11—allergic rhinitis	5.05e-05	0.0197	CbGpPWpGaD
Buprenorphine—OPRL1—Circadian rythm related genes—ADIPOQ—allergic rhinitis	4.71e-05	0.0184	CbGpPWpGaD
Buprenorphine—OPRL1—GPCR ligand binding—CYSLTR1—allergic rhinitis	3.99e-05	0.0155	CbGpPWpGaD
Buprenorphine—OPRM1—IL4-mediated signaling events—IL5—allergic rhinitis	3.94e-05	0.0154	CbGpPWpGaD
Buprenorphine—OPRL1—GPCR ligand binding—CCL11—allergic rhinitis	3.85e-05	0.015	CbGpPWpGaD
Buprenorphine—OPRL1—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	3.67e-05	0.0143	CbGpPWpGaD
Buprenorphine—OPRD1—G alpha (i) signalling events—PTGDR2—allergic rhinitis	3.58e-05	0.014	CbGpPWpGaD
Buprenorphine—OPRD1—GPCRs, Class A Rhodopsin-like—PTGDR2—allergic rhinitis	3.32e-05	0.0129	CbGpPWpGaD
Buprenorphine—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFKB1—allergic rhinitis	3.29e-05	0.0128	CbGpPWpGaD
Buprenorphine—OPRD1—Peptide ligand-binding receptors—CCL11—allergic rhinitis	3.22e-05	0.0125	CbGpPWpGaD
Buprenorphine—OPRM1—TCR Signaling Pathway—IL17A—allergic rhinitis	3.15e-05	0.0123	CbGpPWpGaD
Buprenorphine—OPRK1—G alpha (i) signalling events—PTGDR2—allergic rhinitis	3.14e-05	0.0122	CbGpPWpGaD
Buprenorphine—OPRK1—GPCRs, Class A Rhodopsin-like—PTGDR2—allergic rhinitis	2.91e-05	0.0114	CbGpPWpGaD
Buprenorphine—OPRM1—IL4-mediated signaling events—IL10—allergic rhinitis	2.88e-05	0.0112	CbGpPWpGaD
Buprenorphine—OPRL1—GPCR downstream signaling—PTGDR2—allergic rhinitis	2.87e-05	0.0112	CbGpPWpGaD
Buprenorphine—OPRD1—Class A/1 (Rhodopsin-like receptors)—PTGDR2—allergic rhinitis	2.85e-05	0.0111	CbGpPWpGaD
Buprenorphine—OPRK1—Peptide ligand-binding receptors—CCL11—allergic rhinitis	2.82e-05	0.011	CbGpPWpGaD
Buprenorphine—OPRM1—IL4-mediated signaling events—IL4—allergic rhinitis	2.81e-05	0.0109	CbGpPWpGaD
Buprenorphine—OPRL1—GPCR ligand binding—TAC1—allergic rhinitis	2.8e-05	0.0109	CbGpPWpGaD
Buprenorphine—OPRM1—G alpha (i) signalling events—PTGDR2—allergic rhinitis	2.65e-05	0.0103	CbGpPWpGaD
Buprenorphine—OPRD1—GPCRs, Class A Rhodopsin-like—CYSLTR1—allergic rhinitis	2.61e-05	0.0102	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling by GPCR—PTGDR2—allergic rhinitis	2.61e-05	0.0102	CbGpPWpGaD
Buprenorphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—PTGDR2—allergic rhinitis	2.5e-05	0.00973	CbGpPWpGaD
Buprenorphine—OPRM1—GPCRs, Class A Rhodopsin-like—PTGDR2—allergic rhinitis	2.46e-05	0.0096	CbGpPWpGaD
Buprenorphine—OPRM1—Peptide ligand-binding receptors—CCL11—allergic rhinitis	2.38e-05	0.00929	CbGpPWpGaD
Buprenorphine—OPRD1—Peptide ligand-binding receptors—TAC1—allergic rhinitis	2.34e-05	0.00911	CbGpPWpGaD
Buprenorphine—ABCG2—HIF-1-alpha transcription factor network—SMAD3—allergic rhinitis	2.29e-05	0.00893	CbGpPWpGaD
Buprenorphine—OPRK1—GPCRs, Class A Rhodopsin-like—CYSLTR1—allergic rhinitis	2.29e-05	0.00891	CbGpPWpGaD
Buprenorphine—OPRL1—GPCR downstream signaling—CYSLTR1—allergic rhinitis	2.25e-05	0.00878	CbGpPWpGaD
Buprenorphine—OPRD1—Class A/1 (Rhodopsin-like receptors)—CYSLTR1—allergic rhinitis	2.23e-05	0.00871	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR ligand binding—PTGDR2—allergic rhinitis	2.17e-05	0.00845	CbGpPWpGaD
Buprenorphine—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCL11—allergic rhinitis	2.16e-05	0.00841	CbGpPWpGaD
Buprenorphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—PTGDR2—allergic rhinitis	2.11e-05	0.00822	CbGpPWpGaD
Buprenorphine—ABCB1—Allograft Rejection—FOXP3—allergic rhinitis	2.08e-05	0.00812	CbGpPWpGaD
Buprenorphine—OPRK1—Peptide ligand-binding receptors—TAC1—allergic rhinitis	2.05e-05	0.00799	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling by GPCR—CYSLTR1—allergic rhinitis	2.05e-05	0.00797	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling by GPCR—CCL11—allergic rhinitis	1.98e-05	0.0077	CbGpPWpGaD
Buprenorphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—CYSLTR1—allergic rhinitis	1.96e-05	0.00763	CbGpPWpGaD
Buprenorphine—OPRM1—GPCRs, Class A Rhodopsin-like—CYSLTR1—allergic rhinitis	1.93e-05	0.00753	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR ligand binding—PTGDR2—allergic rhinitis	1.9e-05	0.00741	CbGpPWpGaD
Buprenorphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCL11—allergic rhinitis	1.89e-05	0.00737	CbGpPWpGaD
Buprenorphine—ABCB1—Allograft Rejection—HLA-G—allergic rhinitis	1.89e-05	0.00737	CbGpPWpGaD
Buprenorphine—ABCB1—Allograft Rejection—IL13—allergic rhinitis	1.78e-05	0.00694	CbGpPWpGaD
Buprenorphine—OPRM1—Peptide ligand-binding receptors—TAC1—allergic rhinitis	1.73e-05	0.00675	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR ligand binding—CYSLTR1—allergic rhinitis	1.7e-05	0.00663	CbGpPWpGaD
Buprenorphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CYSLTR1—allergic rhinitis	1.66e-05	0.00645	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR ligand binding—CCL11—allergic rhinitis	1.64e-05	0.0064	CbGpPWpGaD
Buprenorphine—ABCB1—Allograft Rejection—IL17A—allergic rhinitis	1.64e-05	0.00639	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR ligand binding—PTGDR2—allergic rhinitis	1.61e-05	0.00626	CbGpPWpGaD
Buprenorphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL11—allergic rhinitis	1.6e-05	0.00623	CbGpPWpGaD
Buprenorphine—OPRL1—GPCR downstream signaling—TAC1—allergic rhinitis	1.58e-05	0.00616	CbGpPWpGaD
Buprenorphine—OPRD1—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	1.57e-05	0.00611	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—PTGDR2—allergic rhinitis	1.54e-05	0.006	CbGpPWpGaD
Buprenorphine—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TGFB1—allergic rhinitis	1.53e-05	0.00595	CbGpPWpGaD
Buprenorphine—ABCB1—Allograft Rejection—IL5—allergic rhinitis	1.52e-05	0.00594	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR ligand binding—CYSLTR1—allergic rhinitis	1.49e-05	0.00581	CbGpPWpGaD
Buprenorphine—OPRL1—GPCR downstream signaling—IL5—allergic rhinitis	1.47e-05	0.00573	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR ligand binding—CCL11—allergic rhinitis	1.44e-05	0.00561	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling by GPCR—TAC1—allergic rhinitis	1.44e-05	0.00559	CbGpPWpGaD
Buprenorphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	1.37e-05	0.00536	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling by GPCR—IL5—allergic rhinitis	1.33e-05	0.0052	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR ligand binding—CYSLTR1—allergic rhinitis	1.26e-05	0.00491	CbGpPWpGaD
Buprenorphine—CYP2C19—Melatonin metabolism and effects—NFKB1—allergic rhinitis	1.25e-05	0.00485	CbGpPWpGaD
Buprenorphine—ABCB1—HIF-1-alpha transcription factor network—SMAD3—allergic rhinitis	1.24e-05	0.00483	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR downstream signaling—PTGDR2—allergic rhinitis	1.23e-05	0.00477	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR ligand binding—CCL11—allergic rhinitis	1.22e-05	0.00474	CbGpPWpGaD
Buprenorphine—OPRM1—TCR Signaling Pathway—CD4—allergic rhinitis	1.22e-05	0.00474	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—CYSLTR1—allergic rhinitis	1.21e-05	0.00471	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR ligand binding—TAC1—allergic rhinitis	1.19e-05	0.00465	CbGpPWpGaD
Buprenorphine—ABCB1—Allograft Rejection—HLA-DQB1—allergic rhinitis	1.18e-05	0.0046	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—CCL11—allergic rhinitis	1.17e-05	0.00455	CbGpPWpGaD
Buprenorphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	1.16e-05	0.00453	CbGpPWpGaD
Buprenorphine—CYP2D6—Melatonin metabolism and effects—NFKB1—allergic rhinitis	1.15e-05	0.00446	CbGpPWpGaD
Buprenorphine—ABCB1—Allograft Rejection—IL10—allergic rhinitis	1.11e-05	0.00434	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—PTGDR2—allergic rhinitis	1.11e-05	0.00434	CbGpPWpGaD
Buprenorphine—ABCB1—Allograft Rejection—IL4—allergic rhinitis	1.08e-05	0.00422	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR downstream signaling—PTGDR2—allergic rhinitis	1.07e-05	0.00419	CbGpPWpGaD
Buprenorphine—OPRM1—TCR Signaling Pathway—NFKB1—allergic rhinitis	1.05e-05	0.00408	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR ligand binding—TAC1—allergic rhinitis	1.05e-05	0.00408	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—PTGDR2—allergic rhinitis	9.76e-06	0.0038	CbGpPWpGaD
Buprenorphine—CYP1A2—Melatonin metabolism and effects—NFKB1—allergic rhinitis	9.71e-06	0.00378	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR downstream signaling—CYSLTR1—allergic rhinitis	9.61e-06	0.00375	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—PTGDR2—allergic rhinitis	9.08e-06	0.00354	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR ligand binding—TAC1—allergic rhinitis	8.85e-06	0.00345	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—CYSLTR1—allergic rhinitis	8.73e-06	0.0034	CbGpPWpGaD
Buprenorphine—OPRM1—TCR Signaling Pathway—TGFB1—allergic rhinitis	8.72e-06	0.0034	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—TAC1—allergic rhinitis	8.48e-06	0.0033	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—CCL11—allergic rhinitis	8.43e-06	0.00329	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR downstream signaling—CYSLTR1—allergic rhinitis	8.43e-06	0.00328	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—PTGDR2—allergic rhinitis	8.25e-06	0.00321	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—IL5—allergic rhinitis	7.88e-06	0.00307	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—CYSLTR1—allergic rhinitis	7.66e-06	0.00298	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—CCL11—allergic rhinitis	7.39e-06	0.00288	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—CYSLTR1—allergic rhinitis	7.13e-06	0.00278	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR downstream signaling—TAC1—allergic rhinitis	6.75e-06	0.00263	CbGpPWpGaD
Buprenorphine—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—allergic rhinitis	6.71e-06	0.00261	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—PTGDR2—allergic rhinitis	6.57e-06	0.00256	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—CYSLTR1—allergic rhinitis	6.47e-06	0.00252	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR downstream signaling—IL5—allergic rhinitis	6.27e-06	0.00244	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—CCL11—allergic rhinitis	6.25e-06	0.00243	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—TAC1—allergic rhinitis	6.13e-06	0.00239	CbGpPWpGaD
Buprenorphine—UGT1A9—NRF2 pathway—TGFB1—allergic rhinitis	6.06e-06	0.00236	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR downstream signaling—TAC1—allergic rhinitis	5.92e-06	0.00231	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—PTGDR2—allergic rhinitis	5.76e-06	0.00225	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—IL5—allergic rhinitis	5.7e-06	0.00222	CbGpPWpGaD
Buprenorphine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—allergic rhinitis	5.59e-06	0.00218	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—SMAD3—allergic rhinitis	5.55e-06	0.00216	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR downstream signaling—IL5—allergic rhinitis	5.5e-06	0.00214	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—TAC1—allergic rhinitis	5.37e-06	0.00209	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—CYSLTR1—allergic rhinitis	5.16e-06	0.00201	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—TAC1—allergic rhinitis	5e-06	0.00195	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—IL5—allergic rhinitis	4.99e-06	0.00195	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—CCL11—allergic rhinitis	4.98e-06	0.00194	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—PTGDR2—allergic rhinitis	4.87e-06	0.0019	CbGpPWpGaD
Buprenorphine—CYP2A6—NRF2 pathway—TGFB1—allergic rhinitis	4.67e-06	0.00182	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—IL5—allergic rhinitis	4.65e-06	0.00181	CbGpPWpGaD
Buprenorphine—ABCB1—Allograft Rejection—TGFB1—allergic rhinitis	4.54e-06	0.00177	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—TAC1—allergic rhinitis	4.54e-06	0.00177	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—CYSLTR1—allergic rhinitis	4.52e-06	0.00176	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—CCL11—allergic rhinitis	4.37e-06	0.0017	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—IL5—allergic rhinitis	4.22e-06	0.00164	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—CYSLTR1—allergic rhinitis	3.82e-06	0.00149	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—CCL11—allergic rhinitis	3.69e-06	0.00144	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—TAC1—allergic rhinitis	3.62e-06	0.00141	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—IL5—allergic rhinitis	3.36e-06	0.00131	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—TAC1—allergic rhinitis	3.17e-06	0.00124	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—IL5—allergic rhinitis	2.95e-06	0.00115	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—NFKB1—allergic rhinitis	2.82e-06	0.0011	CbGpPWpGaD
Buprenorphine—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—allergic rhinitis	2.69e-06	0.00105	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—TAC1—allergic rhinitis	2.68e-06	0.00105	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—IL5—allergic rhinitis	2.49e-06	0.000972	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—SMAD3—allergic rhinitis	2.37e-06	0.000923	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—TGFB1—allergic rhinitis	2.35e-06	0.000915	CbGpPWpGaD
Buprenorphine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—allergic rhinitis	2.24e-06	0.000874	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—SMAD3—allergic rhinitis	2.08e-06	0.000809	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—SMAD3—allergic rhinitis	1.76e-06	0.000684	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—NFKB1—allergic rhinitis	1.2e-06	0.000469	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—NFKB1—allergic rhinitis	1.06e-06	0.000411	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—TGFB1—allergic rhinitis	1e-06	0.000391	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—NFKB1—allergic rhinitis	8.92e-07	0.000348	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—TGFB1—allergic rhinitis	8.79e-07	0.000343	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—TGFB1—allergic rhinitis	7.43e-07	0.00029	CbGpPWpGaD
